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Alzheimer’s disease (AD) is the most common form of progressive neurodegenerative dementia1. Considering 
that the main risk factor of the disease is age2 and that average life-expectancy increases, the associated personal, 
social and socio-economic burden will intensify if we do not find an effective treatment. Two major pathological 
hallmarks of AD are amyloid beta (Aβ) senile plaques and tau neurofibrillary tangles (NFTs)1. These changes 
are accompanied by neuroinflammation, aberrant synaptic and neuronal network activities3–5, and eventually 
dramatic brain shrinkage due to neuronal damage1. A clear understanding of the specific role of Aβ plaques and 
NFTs and their interaction in (functional) aspects of the disease remains a topic of investigation. Available evi-
dence suggests a model of AD progression with three phases: preclinical AD, mild cognitive impairment (MCI), 
and clinical AD. The preclinical AD starts around 20 years before AD full symptoms’ onset and is characterized 
by Aβ accumulation in the cortex without any neurological symptoms. During MCI some cognitive symptoms 
as well as tauopathy start to emerge. At the clinical AD phase, severe symptoms of dementia are accompanied by 
irreversible neurodegeneration6,7. It is presently believed that the best chance of therapeutic success in AD may be 
early intervention during the preclinical AD phase.
Numerous animal models mirroring some features of AD pathogenesis have been created to facilitate the 
understanding of the molecular mechanisms of the disease8. Among the most common models are transgenic 
mouse models overexpressing the human amyloid precursor protein (APP) with mutations linked to familial AD 
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in APP or/and presenilin 1 and 27. Although these animals have been instrumental in understanding some basic 
aspects of AD7, the overexpression of these proteins might lead to artificial phenotypes9,10. At the brain network 
level, it has been reported by numerous studies that these mouse models demonstrate various alterations11–13, 
even before Aβ accumulation14. Although these results show some phenotypical similarities with AD3,15,16, it is 
not clear what are the underlying mechanisms that cause the aberrant neuronal activity observed in these mod-
els. Some evidence suggests that APP overexpression, and not Aβ overproduction might be responsible for the 
abnormal network activity in APP-overexpressing mouse models10. Further evidence supporting this hypothesis, 
comes from studies investigating the physiological role of APP or its processed fragments in non-pathological 
conditions17,18. For instance, it has been demonstrated that sAPPα (one of the APP fragments) plays a role in the 
modulation of synaptic transmission17.
In 2014, Saito and colleagues developed a new generation of APP Knock-In (KI) mice that produce 
robust Aβ amyloidosis with physiological APP levels9,19. These mice express humanized Aβ with either one 
(Swedish, AppNL), two (Swedish and Beyreuther/Iberian, AppNL-F), or three (Swedish, Beyreuther/Iberian, 
and Artic, AppNL-G-F) familial AD mutations. While Aβ plaque deposition starts at 6 months in AppNL-F 
mice19, its onset in AppNL-G-F mice is already at 2 months and saturates around 7 months19,20. In contrast, 
AppNL mice do not develop any Aβ plaques, even at late ages19,20. Behaviorally, AppNL-G-F mice demonstrate 
impairments in multiple cognitive domains, including declined spatial reversal learning and attention 
control, loss of avoidance memory, and enhanced impulsivity and compulsivity, starting at 8 months of 
age21. Studies investigating early time points show more inconclusive results. For instance, while in the 
original report, deficits in the Y-maze were indicated19, a later study did not find deficits in working mem-
ory using the Y-maze at 6 months of age22. Another study testing AppNL-G-F mice at 3, 6, and 10 months 
demonstrated largely unaffected behavioral readouts, with only mild changes in social and anxiety-related 
test performance23. Brown et al., investigated network hyperexcitability in two mouse models: AppNL-Fand 
J20 (APP-overexpression). Although they were able to replicate the previously reported effect on network 
hyperexcitability in the J20 mice, the effect was absent in AppNL-F mice24.
The App-KI models have not yet been fully characterized with respect to neuronal network activity. 
Therefore, the primary goal of this study was to investigate electrophysiological readouts in combination with 
a cognitive task to illuminate functional differences between AppNL-G-F mice and wild-type C57BL/6J (WT) 
controls. Mice had to perform a visual discrimination (VD) task using touch-screen operant boxes, starting 
at 4.5 months of age while local field potentials (LFPs) in the dorsal medial striatum (DMS), cingulate cortex 
(Cg), retrosplenial cortex (RSC), and dorsal CA1 (dCA1) region of the hippocampus were recorded using a 
wireless neurophysiological signal acquisition system. This approach has multiple advantages: Firstly, the use of 
a wireless LFP recording system allowed the mice to move freely in the operant box. Secondly, the touch-screen 
platform permitted a high level of standardization and lowered the motoric demands on the mice25. Finally, the 
synchronization of LFPs with different behavioral parameters enabled a precise quantification of electrophysi-
ological changes related to behavioral performance; thus, making optimal use of the high temporal resolution 
of LFPs recording techniques. In parallel with these recordings, we measured LFPs at two time-points during 
home-cage exploration, without the behavioral task to investigate neuronal network changes exclusively asso-
ciated with pathology progression. The ages to perform the in vivo experiments were selected with the objective 
to match the preclinical AD phase. Biochemical and immunohistochemical analysis were conducted to corre-
late Aβ plaque deposition with the electrophysiological and behavioral results at the different time-points. The 
electrophysiological analysis focussed on phase-amplitude coupling (PAC) between theta (4–12 Hz), gamma 
(30–100 Hz), and high-frequency oscillations (100–200 Hz, HFO) activity during three distinct recording con-
ditions related to different cognitive load, the start and the end of the VD task, and exploration of the home 
environment. PAC has been suggested to be a potential mechanism to regulate neuronal communication in 
multiple brain regions26–28. Furthermore, neuronal oscillations are affected in pathological conditions. For 
instance, neurodegenerative diseases are characterized by, among others, a disruption of gamma oscillations, 
which in turn is associated with the cognitive deficits3. In addition to new insights into pathological processes 
of this second-generation mouse model of Aβ amyloid pathology, our approach provides a versatile tool to fur-
ther assess the complex interplay between different frequency bands and their relationship with behavior. The 
combination of these techniques may therefore open new avenues for the investigation of cognition-related 
network perturbations in relevant animal models of AD pathology, eventually determining their translational 
validity and potential use as biomarkers in drug discovery and development.
Results
Performance during the visual discrimination (VD) task.  Pre-training. During the pre-training stage 
there were no genotype effects on the number of sessions required in the tone association (WT: M = 3.9, SD = 0.7, 
n = 10; AppNL-G-F: M = 4.5, SD = 0.5, n = 8, Z = 3.74, p = 0.05), touch association (WT: M = 1.2, SD = 0.6, n = 10; 
AppNL-G-F: M = 1.0, SD = 0.0, n = 8, Z = 0.8, p = 0.37), must touch (WT: M = 1.4, SD = 0.8, n = 10; AppNL-G-F: 
M = 1.4, SD = 1.1, n = 8, Z = 0.07, p = 0.78) and punish incorrect (WT: M = 3.9, SD = 1.4, n = 10; AppNL-G-F: 
M = 4.3, SD = 1.4, n = 7, Z = 0.31, p = 0.57) stages of touch-screen pre-training. One AppNL-G-F mouse did not 
complete all pre-training stages within 30 days and did not progress onto the VD task.
Discrimination task. The individual learning curves of mice during acquisition of the VD task are shown in 
Fig. 1a. As expected, percentage of correct responses on the first day of the discrimination task was around 
chance level (WT: M = 49.17%, SD = 12.46, n = 10; AppNL-G-F: M = 52.97%, SD = 10.61, n = 7) and no difference 
was found between genotypes t (15) = 0.656, p = 0.52. To compare learning rates, a mixed linear model was 
used to fit the percentage of correct responses data (R2 = 0.715). There was a significant effect of session F (1, 
139.6) = 252.3, p < 0.0001, and a significant interaction of session and genotype F (1, 139.6) = 29.07, p < 0.0001. 
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The main genotype effect did not reach significance F (1, 14.7) = 2.375, p = 0.1445. One mouse in the AppNL-G-F 
group needed 24 sessions to reach the VD criterion, twice that of the slowest learner in the WT group. Excluding 
this extreme value from the model fit resulted in a non-significant interaction term between genotype and ses-
sion F (1, 115.5) = 3.668, p = 0.0580. Analysis of the number of sessions required to reach the learning criterion 
of two consecutive sessions of 80% correct responses or higher did not identify a significant difference between 
groups (WT: M = 7.4%, SD = 2.91, n = 10; AppNL-G-F: M = 11.43%, SD = 5.94, n = 7, Z = 2.95, p = 0.08, Fig. 1b). 
Similarly, a comparison of the percentage of correction trials (CTs) did not indicate a genotype difference (WT: 
M = 32.24%, SD = 5.24, n = 10; AppNL-G-F: M = 33.54%, SD = 6.08, n = 7, Z = 0.15, p = 0.69, Fig. 1c). Analysis of 
latencies to initiate trials (WT: M = 4.54%, SD = 1.86, n = 10; AppNL-G-F: M = 5.51%, SD = 2.9, n = 7, Z = 0.61, 
p = 0.43, Fig. 2d), response to the stimulus (WT: M = 5.07%, SD = 0.87, n = 10; AppNL-G-F: M = 7.69%, SD = 6.07, 
n = 7, Z = 0.95, p = 0.33, Fig. 1e), and to collect the food reward (WT: M = 2.04%, SD = 0.34, n = 10; AppNL-G-F: 
M = 2.28%, SD = 0.89, n = 7, Z = 0.15, p = 0.69, Fig. 1f) indicated no alterations in any response latencies for 
the AppNL-G-F mice. Together these results suggest that the ability to discriminate visual stimuli and to form 
stimulus-reward associations was largely unaffected in the AppNL-G-F mice.
Analysis of brain oscillations during the VD task. Relative Power Spectral Density (PSD). Before 
investigating the relative PSD in the four brain areas of interest during the start and end of the VD task, we 
grouped frequencies on three bands: theta (4 to 12 Hz), gamma (30 to 100 Hz) and HFO (101 to 200 Hz), based on 
previous proposed guidelines29. A within-subject analysis between the end and start of the VD task revealed no 
significant difference in relative PSD for any of the frequency bands for both genotypes (see Fig. 3 with Cg brain 
area as an example and Table 1 for all descriptive statistics and statistical tests). We also investigated relative PSD 
between WT and AppNL-G-F, but no significant differences were found for any of the brain areas and frequency 
bands (Supplementary Table 1).
Figure 1. Acquisition of the visual discrimination (VD) touch-screen task in AppNL-G-F and WT mice. (a) 
Learning curves of mice during discrimination learning for WT (left panel) and AppNL-G-F (right panel) plotting 
percentage correct responses by sessions where each colored line represents an individual mouse. (b) Number 
of sessions to achieve learning criterions of two consecutive sessions of 80% correct or higher responses did 
not differ between WT and AppNL-G-F mice. (c) Percentage of correction trials did not differ between genotypes. 
Latencies, (d) to initiate trial, (e) response to the stimulus, (f) collect the reward did not differ between 
genotypes. In figures b, c, d, e, f data are represented in box plots with individual points for each subject. 
Statistically significance level at p < 0.05. ns: non-significant.
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Phase-Amplitude Coupling (PAC). Similarly to relative PSD analysis, we investigated whether the modula-
tion index (MI) changed as the animals progressed on the VD task and if this modulation was different for the 
AppNL-G-F compared to the WT mice. For this analysis, we grouped amplitude frequencies in three bands: Low 
Gamma (LG, 30–60 Hz), High Gamma (HG, 61–100 Hz), and HFO (101–200 Hz). This banding was selected as 
it has been suggested that different frequency bands act as different channels for communication. For instance, 
in the CA1 region of the hippocampus, gamma oscillations split into two different components indicating differ-
ent origins. Low-gamma arises from interactions with the CA3 region of the hippocampus, while high-gamma 
is thought to arise from interactions with the entorhinal cortex30. A visual inspection of the phase-amplitude 
comodulograms of the different brain areas indicates that PAC occurs in different frequency bands. For instance, 
Cg (Fig. 4a) and RSC (Fig. 5a) show coupling between HFO and higher theta, while the DMS (Fig. 6a) and dCA1 
(Fig. 7a) show coupling between HG and high theta. When investigating the changes in the MI between the end 
and the start of the VD task the most prominent effect was observed in the Cg (Fig. 4b) and RSC (Fig. 5b) for WT 
mice where the MI decreased by the end of the VD. WT mice also demonstrated a similar effect in HFO for the 
DMS (Fig. 6b) and dCA1 (Fig. 7b). Importantly, during the start of the task, the coupling seems to be associated 
with more frequency bands, suggesting that as the mice learned the task, the coupling became more localized. 
These differences were not clearly observed for the AppNL-G-F mice, where they only demonstrated a decreased 
coupling for HG in the Cg (Fig. 4b). See Table 2, for completed descriptive statistics and statistical analysis. Next, 
Figure 2. Visual discrimination (VD) touch-screen task. (a) The spider/plane stimulus image pair used in 
the VD25. In this example, the spider was the rewarded image (conditioned stimulus: S+) and the plane the 
unrewarded (unconditioned stimulus: S−) image. Image contingency was counterbalanced across animals. (b) 
Illustration of the VD task. A trial began with the delivery of a food pellet in the food magazine opposite to 
the touchscreen. Collection of the pellet initiated the trial where the two images appeared on the touchscreen. 
Nose-poking on the S+ stimulus activated the delivery of a food reward and the trial was registered as a correct 
response. Nose-poking the S− stimulus did not delivery a food reward, the light of the operant chamber went 
off for 5 seconds, and the response was registered as incorrect. Incorrect trials were followed by correction 
trials. Grey area represents local field potentials (LFPs) analysis. Epochs of 1.4 seconds immediately preceding 
activation of the touch-screen during correct responses were selected for electrophysiological analysis.
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we investigated genotype differences within each condition. For this, we compared the MI for the three different 
amplitude bands at the start and the end of the task and corrected for multiple comparisons using a false discov-
ery rate (FDR), as done with all previous comparisons (see “Methods” section). Table 3 shows that no significant 
differences were observed between AppNL-G-F and WT mice for any of the brain areas and frequency bands. Note 
that for simplicity, panel c of Figs 4–7 shows box plots of the full amplitude range, but the statistical analysis was 
done for each separate frequency band. It should be noted that some of the mean phase-amplitude comodulo-
grams might visually suggest changes between genotypes, but as it can be seen in the box plots, some of these 
measurements had a high level of variability. The different results obtained for the within and between-subject 
analysis might reflect difference in the experimental design. Importantly, these designs are addressing different 
questions, therefore, they may provide different patterns of results31.
Brain oscillations analysis during home environment exploration. Relative PSD. Our next analy-
sis was conducted to determine if we could observe different brain oscillatory activity when animals were explor-
ing the home environment at an age of 5 months compared to 8 months. As with the relative PSD during the task, 
we did not observe difference for any of the frequency bands between genotypes (Table 4). Furthermore, age did 
not have an effect of the PSD for either the AppNL-G-F and WT mice (Supplementary Table 2).
Phase-amplitude coupling (PAC). As a with the relative PSD, no significant differences were observed between 
genotypes during the home environment exploration (Table 5, Supplementary Figures 1, 2, 3, and 4) for any 
of the brain areas. Furthermore, we did not observe an effect on age for either the WT and AppNL-G-F mice 
(Supplementary Table 3). Taken together, these results suggest that the AppNL-G-F mice demonstrate up to 8 
months of age normal PAC in a freely moving condition without task performance (investigation of further age 
points were beyond the scope of this study).
pathology. Biochemical analysis of AppNL-G-F forebrain tissue revealed that Aβ1–42 increased in an 
age-dependent manner (Fig. 8a) and was accompanied by progressive Aβ plaque pathology as seen by immuno-
histochemistry (Fig. 8b,c). Aβ1–42 levels in the brain seemed to be minor at 2 months of age, but progressively 
increased starting from 4 months of age up to 12–15 months. This can also be deduced from the immunohisto-
chemical evaluation of cortical and hippocampal pathology (% Aβ plaque area as detected by antibodies JRF/
cAβ42/26 and JRF/AβN/25) that showed a limited number of Aβ deposits at 2 months of age in cortex, further 
progressing up to 8–15 months as observed by others19,21,32. Altogether, our data indicate that between 4 and 8 
months of age, the period where mice were used for the in vivo behavioural and neurophysiological characterisa-
tion, increased Aβ1–42 levels and Aβ plaques were present in both cortex and hippocampus.
Figure 3. Mean relative power spectral density (PSD) during the visual discrimination (VD) task for the 
cingulate cortex (Cg). Mean relative PSD in the 4 to 200 Hz band during start of the VD task (Task_Start, black 
and blue curves) and end of the VD task (Task_End, green and red curves) for (a) WT and (c) AppNL-G-F mice. 
Delta between Task_End and Task_Start is represented in box plots were individual points indicate delta values 
for each subject for (b) WT and (d) AppNL-G-F mice. No significant difference was observed between the end and 
the start of the task for the two genotypes at the three different frequency bands. Significance level at q = 0.05, 
false discovery rate (FDR) corrected for multiple comparisons. ns: non-significant.











Task_Start 0.03879 0.01048 0.04082 0.03418
8 −11 0.1484 13 0.02708
Task_End 0.03639 0.00094 0.03746 0.02788
Gamma
Task_Start 0.00540 0.00110 0.00510 0.00360
8 10 0.1953 16 0.03333
Task_End 0.00560 0.00100 0.00550 0.00300
HFO
Task_Start 0.00120 0.00034 0.00120 0.00078
8 13 0.0781 9 0.01875
Task_End 0.00130 0.00036 0.00120 0.00082
AppNL-G-F
Theta
Task_Start 0.04875 0.00666 0.04702 0.01918
7 −10 0.1094 11 0.02292
Task_End 0.04600 0.00860 0.04278 0.02300
Gamma
Task_Start 0.00450 0.00077 0.00460 0.00220
7 12 0.0469 4 0.00833
Task_End 0.00480 0.00083 0.00530 0.00220
HFO
Task_Start 0.00093 0.00020 0.00100 0.00049
7 11 0.0781 8 0.01667




Task_Start 0.04992 0.01000 0.05291 0.03031
10 −1.5 0.9219 23 0.04792
Task_End 0.04901 0.00896 0.05110 0.02459
Gamma
Task_Start 0.00420 0.00062 0.00440 0.00200
10 4.5 0.6953 22 0.04583
Task_End 0.00440 0.00068 0.00430 0.00190
HFO
Task_Start 0.00019 0.00006 0.00020 0.00017
10 25.5 0.0059 1 0.00208
Task_End 0.00025 0.00013 0.00023 0.00049
AppNL-G-F
Theta
Task_Start 0.05863 0.00790 0.06198 0.01952
6 −8.5 0.0938 10 0.02083
Task_End 0.05361 0.00862 0.05439 0.02604
Gamma
Task_Start 0.00360 0.00100 0.00330 0.00300
6 9.5 0.0625 5 0.01042
Task_End 0.00410 0.00120 0.00380 0.00380
HFO
Task_Start 0.00026 0.00011 0.00026 0.00031
6 9.5 0.0625 6 0.01250




Task_Start 0.06310 0.00684 0.06254 0.02294
8 17 0.0156 2 0.00417
Task_End 0.06634 0.00559 0.06502 0.01872
Gamma
Task_Start 0.00320 0.00076 0.00300 0.00250
8 5 0.5469 20 0.04167
Task_End 0.00330 0.00064 0.00340 0.00220
HFO
Task_Start 0.00042 0.00013 0.00037 0.00043
8 −7 0.3828 19 0.03958
Task_End 0.00041 0.00012 0.00039 0.00037
AppNL-G-F
Theta
Task_Start 0.06536 0.00494 0.06540 0.01470
7 −7 0.2969 18 0.03750
Task_End 0.06330 0.01026 0.06251 0.02893
Gamma
Task_Start 0.00320 0.00069 0.00310 0.00210
7 9 0.1563 14 0.02917
Task_End 0.00360 0.00098 0.00320 0.00250
HFO
Task_Start 0.00040 0.00014 0.00039 0.00041
7 7 0.2969 17 0.03542




Task_Start 0.04116 0.00835 0.03904 0.02734
9 −13.5 0.1289 12 0.02500
Task_End 0.03915 0.00799 0.03650 0.02338
Gamma
Task_Start 0.00480 0.00088 0.00490 0.00300
9 15.5 0.0742 7 0.01458
Task_End 0.00510 0.00091 0.00510 0.00280
HFO
Task_Start 0.00119 0.00033 0.00125 0.00093
9 19.5 0.0195 3 0.00625
Task_End 0.00132 0.00031 0.00148 0.00071
AppNL-G-F
Theta
Task_Start 0.04553 0.01188 0.04353 0.03560
7 −1 0.9375 24 0.05000
Task_End 0.04530 0.01254 0.04611 0.03356
Gamma
Task_Start 0.00460 0.00120 0.00460 0.00370
7 3 0.6875 21 0.04375
Task_End 0.00470 0.00120 0.00480 0.00330
HFO
Task_Start 0.00109 0.00027 0.00098 0.00073
7 9 0.1563 15 0.03125
Task_End 0.00103 0.00028 0.00110 0.00078
Table 1. Relative power spectral density (PSD, µV2/Hz) during the visual discrimination (VD) task. Brain 
areas: Cingulate Cortex (Cg), dorsal CA1 region of the hippocampus (dCA1), dorsal medial striatum (DMS), 
and retrosplenial cortex (RSC). Frequencies: theta, gamma and high frequency oscillations (HFO). Conditions: 
Task_Start = start of the VD task, Task_End = end of the VD task. Descriptive statistics for PSD (µV2/Hz), N: 
sample size, Z: Wilcoxon rank-sum test. Significance level at q = 0.05, false discovery rate (FSD) corrected for 
multiple comparisons.
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Discussion
The purpose of this study was to characterize AppNL-G-F mice, a second-generation mouse model of Aβ amy-
loidosis19, by performing behavioral, electrophysiological, and pathological investigations in an age-dependent 
manner. Previous research using APP-overexpressing models (first-generation mouse models) has led to the 
hypothesis that aberrant network and altered oscillatory rhythmic activity caused by Aβ amyloidosis reflect 
and underlie the early cognitive disturbances observed in AD13,16,33. In our study, we tested this hypothesis 
using a more relevant model of AD pathology, as the AppNL-G-F mice produce robust Aβ amyloidosis, like the 
first-generation models34 and AD patients35, but without potential undesirable side effects caused by the overex-
pression of APP9,10.
Behaviorally, the AppNL-G-F mice did not show strong associative learning impairments in the VD task. Overall 
AppNL-G-F mice demonstrated a higher variability than the controls in learning the task. Mice were 4.5 months 
old at the start of the VD task, which correlates with early plaque deposition. Previous studies characterizing the 
new-generation of AD mouse models have identified some minimal behavioral changes at younger ages23, though 
impaired performance on cognitive tests has only been reported from the age of six months onwards19,21,22. Our 
study, using a different behavioral task than those already investigated in this model, contributes to an increasing 
body of evidence indicating that the AppNL-G-F mice do not show severe cognitive impairments at early plaque 
stages. On the other hand, APP-overexpressing models show more variability with respect to the onset of cogni-
tive deficits in relation to pathology8,36.
To investigate the electrophysiological correlates, we used advanced techniques to explore the effects of 
AD-related pathology on neural oscillations in different brain areas during cognition. Electrode placement tar-
geting different brain areas was motivated by two main factors: topographic distribution of amyloid plaques 
in AD patients37 and animal models with Aβ pathology7, and the functional role of these areas on cognitive 
processes associated with the VD task, especially for the DMS, which plays a role in establishing action-reward 
associations38. We focussed our analysis on PAC, as this measurement has been suggested to be associated with 
normal cognitive functioning in humans26,39,40 and rodents27,41–43, and to be disrupted in patients with AD and 
MCI15,44. Our analysis was centered on comparing the start and end of the VD task. At the end of the task, 
Figure 4. Mean phase-amplitude coupling (PAC) during the visual discrimination (VD) task for the cingulate 
cortex (Cg). (a) Phase-amplitude comodulograms plotted for WT mice (top panels) and AppNL-G-F mice (lower 
panels) for start of the VD task (Task_Start, left) and end of the VD task (Task_End, right). (b) Modulation 
index (MI) delta between Task_End and Task_Start for low gamma (LG, left), high gamma (HG, middle) 
and high frequency oscillations (HFO, right) for WT mice (top panels) and AppNL-G-F mice (lower panels). 
Comparison at each frequency band showed a significant different for WT mice, but only at HG for AppNL-G-F 
mice. (c) MI between WT and AppNL-G-F mice for Task_Start (left) and Task_End (right). Comparison at each 
frequency band showed no significant difference. Values are represented in box plots were individual points 
indicate (b) delta or (c) absolute values for each subject. Significance level at q = 0.05, false discovery rate (FSD) 
corrected for multiple comparisons. ns: non-significant.
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the relationship between decision making and coupling could be easily assessed, as mice were at 80% or higher 
accuracy. For the start of the task, the interpretation was more difficult, as mice were responding at chance level; 
therefore, some of the correct trial responses analysis could include brain activity that may or may not pertain 
to decision making. We believe that some of the non-specific coupling observed at the start of the task could be 
associated with this mentioned variability within correct responses. Our results indicate a decrease in coupling 
for the WT mice as they learned the task, especially for the Cg and RSC. This result is in accordance with previ-
ous research indicating that PAC increases with task difficulty26,45. For the AppNL-G-F mice, this decrease was less 
pronounced, only reaching statistical significance for HG in the Cg. Importantly, between-subject comparisons 
did not reveal significant differences between the two genotypes. Notable there was no effect on power for any of 
the tested comparisons. On the other hand, multiple studies using different transgenic rodent models including 
human APP-overexpression transgenes with different familial AD mutations have demonstrated gamma power 
alterations46–48 as well as PAC dysfunctions14,48 before major amyloid plaque accumulation. Furthermore, studies, 
such as the ones carried out by Poza and colleagues15 or Dimitriadis and colleagues44 provide valuable insights to 
better understand PAC changes associated with the disease, but both studies reported PAC alterations in AD and 
MCI patients respectively. Considering the difficulty to recruit patients in the preclinical phase, relevant animal 
models could help to further understand the potential use of PAC measurement as a biomarker for AD. The 
AppNL-G-F mice at the ages investigated in our study demonstrate Aβ accumulation without clear cognitive symp-
toms, making them a relevant preclinical AD model. Altogether our results indicate very subtle changes in cou-
pling, suggesting PAC might not be affected in the preclinical phase of AD based on amyloidosis pathology only. 
It remains to be tested if other brain areas or the interaction between them might reveal changes in PAC at these 
early stages. Furthermore, other complex functional connectivity analysis that has been explored in patients49, 
should be investigated in this and other animal models of AD pathology.
Our main motivation for this study was to investigate PAC, for which a role in neuronal information process-
ing was reported40, in a second-generation mouse model while animals performed the task. In addition, we were 
also interested in investigating PAC without any influence that the VD task could have on this readout. To this 
end, we measured LFPs when mice were exploring their home environment at 5 and 8 months of age. Despite 
Figure 5. Mean phase-amplitude coupling (PAC) during the visual discrimination (VD) task for the 
retrosplenial cortex (RSC). (a) Phase-amplitude comodulograms plotted for WT mice (top panels) and  
AppNL-G-F mice (lower panels) for start of the VD task (Task_Start, left) and end of the VD task (Task_End, 
right). (b) Modulation index (MI) delta between Task_End and Task_Start for low gamma (LG, left), high 
gamma (HG, middle) and high frequency oscillations (HFO, right) for WT mice (top panels) and AppNL-G-F 
mice (lower panels). Comparison at each frequency band showed a significant different for WT mice at LG 
and HG, but no significant difference for AppNL-G-F mice. (c) MI between WT and AppNL-G-F mice for Task_Start 
(left) and Task_End (right). Comparison at each frequency band showed no significant difference. Values 
are represented in box plots were individual points indicate (b) delta or (c) absolute values for each subject. 
Significance level at q = 0.05, false discovery rate (FSD) corrected for multiple comparisons. ns: non-significant.
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seeing an age-dependent increase in Aβ pathology between these time-points, we did not observe changes in 
PAC for any of the brain regions. Importantly, the ages for recording were selected based on previous reports of 
pathology19. Our objective was to obtain two measurements: one at a relatively early plaque stage and a second 
one at a later time-point where amyloid pathology is at an advanced state. Our findings indicate an age-dependent 
increase in Aβ1–42 levels and plaque deposition that are consistent with previous research19,21,32. Previous reports 
indicated the absence of hyperexcitability in the AppNL-G-F at 8 and 12 months of age24 and subtle synaptic alter-
ations at around 18 months50. However, other reports have indicated theta-gamma coupling impairments in the 
entorhinal cortex of AppNL-G-F mice at 5 months of age51 and hypersynchronous functional connectivity of brain 
networks using resting-state functional MRI in AppNL-G-F mice at 3 months (pre-plaque stage)52. Taken together, 
these studies suggest that there is evidence for disruptions in network function under certain circumstances, 
but these are not apparent with all methodologies. Further work is needed to better understand how the var-
iability in the methods and measurements of these studies leads to different outcomes about different aspects 
of network integrity in these animals. Finally, an important consideration for the translatability of findings in 
second-generation models is that while they avoid potential artefacts associated with the overexpression of APP, 
the development of pathology relies on several mutations linked to familial forms of AD, and may not accu-
rately recreate the pathological processes in sporadic forms of AD. Furthermore, like the first-generation models, 
the AppNL-G-F mice do not exhibit tau pathology or neurodegeneration, which are important components of AD 
pathology.
Altogether, our results do not support the hypothesis of early alterations in oscillations and functional neu-
ronal activity13,14,33 postulated using the first-generation models. We believe that by allowing researchers to disso-
ciate the effects of APP overexpression from the pathophysiological changes in AD, the second-generation models 
will facilitate a deeper understanding of the neurobiology of the disease. In AD patients changes in electroen-
cephalography (EEG) power spectral or synchronization have been commonly reported3,49,53,54. Although some 
of these studies used new guidelines for diagnosis and investigated preclinical (before cognitive symptoms) and 
clinical AD; the reliability of the AD diagnosis in other studies must be considered with caution, given the lack of 
available biomarkers at the time of the studies. For instance, it has been indicated that the discrepancy between 
Figure 6. Mean phase-amplitude coupling (PAC) during the visual discrimination (VD) task for the dorsal 
medial striatum (DMS). (a) Phase-amplitude comodulograms plotted for WT mice (top panels) and AppNL-G-F 
mice (lower panels) for start of the VD task (Task_Start, left) and end of the VD task (Task_End, right). (b) 
Modulation index (MI) delta between Task_End and Task_Start for low gamma (LG, left), high gamma (HG, 
middle) and high frequency oscillations (HFO, right) for WT mice (top panels) and AppNL-G-F mice (lower 
panels). Comparison at each frequency band showed a significant different for WT mice at HFO, but no 
significant difference for AppNL-G-F mice. (c) MI between WT and AppNL-G-F mice for Task_Start (left) and Task_
End (right). Comparison at each frequency band showed no significant difference. Values are represented in box 
plots were individual points indicate (b) delta or (c) absolute values for each subject. Significance level at q = 0.05, 
false discovery rate (FSD) corrected for multiple comparisons. ns: non-significant.
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clinical and pathological diagnosis is about 20%55. Many studies have also shown that AD patients have a higher 
risk of developing seizures and epilepsy56–58; however, the reported prevalence in the literature fluctuates from 
1.5 to 64%5. Furthermore, it is still unclear whether neuronal alterations occur rather at a late stage of the disease 
as a consequence of neurodegeneration, or at an early stage as a primary mechanism contributing to cognitive 
dysfunction. If the second conjecture is correct, the potential value of having a reliable biomarker of preclinical 
and early stages of the AD could have a major impact on the disease diagnostics. Our knowledge about the 
pathophysiology of neural networks in AD is limited and more research is urgently needed. In parallel to research 
carried-out with patients, studies investigating electrophysiological readouts of the AppNL-G-F model could also 
help to gain new insights and outline a timeline on network changes associated with AD pathology.
Methods
In Vivo Experiments Methods.  Animals. Data were obtained from eight homozygous male AppNL-G-F 
mice (generated by Saito and colleagues19 and obtained from the Janssen transgenic rodent facility, Belgium) and 
ten age-matched non-litter mates WT C57BL/6J male mice (Charles River, France). Mice were singly housed in 
individually ventilated cages under a reversed 12–12 light cycle (lights off 07:00–19:00; light intensity ~100 lux) 
under controlled environmental conditions throughout the study (22 ± 2 °C ambient temperature and relative 
humidity at 60%). Home cages were equipped with corn cob bedding, a tinted polycarbonate shelter and tissue for 
nesting material and ad libitum water. Throughout pre-training and cognitive testing, mice were provided with a 
restricted diet (Dustless precision pellets, Bioserv, USA) to maintain them at 80% free-fed weight to ensure con-
sistent motivation towards reward pellets. All behavioral testing was conducted during the dark phase to obtain 
optimal engagement in the behavioral task as this is the active phase of the circadian cycle in mice.
All in vivo and in vitro studies were performed in strict accordance with the guidelines of the Association 
for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and with the European 
Council Directive of 24 November 1986 (86/609/EEC) and European Ethics Committee directive (2010/63/EU) 
for the protection of laboratory animals. In line with Belgian governmental directives all protocols were approved 
by the Animal Care and Use Committee of Janssen Pharmaceutica NV.
Figure 7. Mean phase-amplitude coupling (PAC) during the visual discrimination (VD) task for the dorsal 
CA1 region of the hippocampus (dCA1). (a) Phase-amplitude comodulograms plotted for WT mice (top 
panels) and AppNL-G-F mice (lower panels) for start of the VD task (Task_Start, left) and end of the VD task 
(Task_End, right). (b) Modulation index (MI) delta between Task_End and Task_Start for low gamma (LG, left), 
high gamma (HG, middle) and high frequency oscillations (HFO, right) for WT mice (top panels) and AppNL-G-F 
mice (lower panels). Comparison at each frequency band showed a significant different for WT mice at HFO, 
but no significant difference for AppNL-G-F mice. (c) MI between WT and AppNL-G-F mice for Task_Start (left) and 
Task_End (right). Comparison at each frequency band showed no significant difference. Values are represented 
in box plots were individual points indicate (b) delta or (c) absolute values for each subject. Significance level at 
q = 0.05, false discovery rate (FSD) corrected for multiple comparisons. ns: non-significant.









Task_Start 0.000136 0.000054 0.000133 0.000150
8
−17 0.0156 7 0.0145833
Task_End 0.000060 0.000020 0.000066 0.000048
HG
Task_Start 0.000167 0.000056 0.000164 0.000201
−17 0.0156 6 0.0125
Task_End 0.000072 0.000034 0.000065 0.000094
HFO
Task_Start 0.000271 0.000060 0.000283 0.000193
−18 0.0078 1 0.0020833
Task_End 0.000138 0.000051 0.000143 0.000172
AppNL-G-F
LG
Task_Start 0.000119 0.000074 0.000124 0.000214
7
−8 0.2188 20 0.0416667
Task_End 0.000073 0.000035 0.000085 0.000084
HG
Task_Start 0.000219 0.000173 0.000181 0.000506
−11 0.0781 15 0.03125
Task_End 0.000099 0.000040 0.000098 0.000120
HFO
Task_Start 0.000247 0.000090 0.000229 0.000249
−14 0.0156 8 0.0166667




Task_Start 0.000852 0.000477 0.000713 0.001435
10
−13.5 0.1934 19 0.0395833
Task_End 0.000719 0.000499 0.000732 0.001614
HG
Task_Start 0.003142 0.003040 0.001842 0.002389
−14.5 0.1602 18 0.0375
Task_End 0.002817 0.003087 0.001674 0.008305
HFO
Task_Start 0.001266 0.001129 0.000807 0.003486
−24.5 0.0098 4 0.0083333
Task_End 0.001019 0.001000 0.000786 0.003212
AppNL-G-F
LG
Task_Start 0.000332 0.000204 0.000310 0.000581
6
1.5 0.8438 24 0.05
Task_End 0.000371 0.000320 0.000257 0.000816
HG
Task_Start 0.001877 0.001494 0.001523 0.004300
−3.5 0.5625 23 0.0479167
Task_End 0.001438 0.008713 0.001322 0.002162
HFO
Task_Start 0.000597 0.000397 0.000438 0.001036
−4.5 0.4375 22 0.0458333




Task_Start 0.000176 0.000071 0.000156 0.000201
8
−15 0.0391 12 0.025
Task_End 0.000115 0.000036 0.000119 0.000092
HG
Task_Start 0.000434 0.000149 0.000443 0.000412
−16 0.0234 10 0.0208333
Task_End 0.000322 0.000130 0.000318 0.000340
HFO
Task_Start 0.000434 0.000112 0.000433 0.000326
−17 0.0156 5 0.0104167
Task_End 0.000276 0.000121 0.000296 0.000390
AppNL-G-F
LG
Task_Start 0.000190 0.000074 0.000205 0.000205
7
−9 0.1563 17 0.0354167
Task_End 0.000136 0.000047 0.000158 0.000120
HG
Task_Start 0.000703 0.000571 0.000494 0.001642
−11 0.0781 14 0.0291667
Task_End 0.000535 0.000505 0.000267 0.001350
HFO
Task_Start 0.000350 0.000098 0.000360 0.000246
−11 0.0781 13 0.0270833




Task_Start 0.000147 0.000071 0.000119 0.000218
9
−19.5 0.0195 9 0.01875
Task_End 0.000075 0.000023 0.000075 0.000067
HG
Task_Start 0.000177 0.000053 0.000181 0.000189
−21.5 0.0078 3 0.00625
Task_End 0.000091 0.000034 0.000087 0.000095
HFO
Task_Start 0.000309 0.000097 0.000326 0.000332
−21.5 0.0078 2 0.0041667
Task_End 0.000196 0.000068 0.000182 0.000178
AppNL-G-F
LG Task_Start 0.000130 0.000091 0.000089 0.000268
7
−6 0.375 21 0.04375
Task_End 0.000084 0.000043 0.000084 0.000129
HG Task_Start 0.000202 0.000118 0.000188 0.000336
−10 0.1094 16 0.0333333
Task_End 0.000098 0.000044 0.000089 0.000120
HFO Task_Start 0.000272 0.000089 0.000302 0.000225
−13 0.0313 11 0.0229167
Task_End 0.000166 0.000096 0.000155 0.000289
Table 2. Phase-amplitude coupling (PAC) during the visual discrimination (VD) task. Brain areas: Cingulate 
Cortex (Cg), dorsal CA1 region of the hippocampus (dCA1), dorsal medial striatum (DMS), and retrosplenial 
cortex (RSC). Frequencies: theta, gamma and high frequency oscillations (HFO). Conditions: Task_Start = start 
of the VD task, Task_End = end of the VD task. Descriptive statistics for Modulation Index (MI), N: sample 
size, Z: Wilcoxon rank-sum test. Significance level at q = 0.05, false discovery rate (FSD) corrected for multiple 
comparisons. Bold cells indicate statistically significant values. P value ranks lower than 8 are statistically 
significant different between the two conditions.
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Surgery. Surgeries were carried out when mice were three months old. The surgeon was blinded to animal gen-
otype before carrying out the procedure. Anesthesia was induced via two minutes isoflurane inhalation (O2, N2O 
and 5% isoflurane) and animals inserted into a stereotactic frame (StereoDrive, Neurostar, Germany). During the 
surgical procedure, anesthesia was maintained using a continuous flow of gas (O2, N2O and 2% isoflurane) delivered 
via inhalation mask. A homeothermic blanket system was used to sustain a stable 37–38 °C body temperature. A 
subcutaneous injection of analgesic Piritramide (dipidolor, 0.025 mg/kg) was administered. As a further precaution 
to minimize pain from the surgery, a local spray analgesic (Xylocaine, 10%) was applied at the surgery site. An inci-
sion was made along the sagittal plane to expose the skull, and the scalp held open using suture thread tied to the 
stereotactic frame. The skull was cleaned using saline solution and dried using swabs and cotton buds. Holes were 
drilled for the placement of four recording electrodes; all coordinates relative to bregma, anterior-posterior (AP), 
medial-lateral (ML), dorsal-ventral (DV)59. Two stainless steel screws were affixed over the left frontal and right 
occipital lobes to secure the implant. Depth electrodes consisted of a single fomvar-insulated tungsten wire (100 μm 
diameter with a blunt-tipped, Peira, Belgium) and were inserted into the DMS (1.4 mm AP, −1 mm ML, 2.5 mm 
DV), and the dCA1 (−1.7 mm AP, −1.5 mm ML, 1.7 mm DV). Surface electrodes (500 μm diameter gold-plated pins, 
Z = 150) were placed in the Cg (−0.5 mm AP, 0.0 mm ML) and the RSC (−1.8 mm AP, 0.0 mm ML). All electrodes 
were referenced to the same ground electrode placed on the midline over the cerebellum (−1.5 mm AP, 0.5 mm ML) 
and grounded by a pin positioned on the midline over the occipital lobe (−5.0 mm AP, 0.0 mm ML). After placing 
all electrodes, a multichannel connector (Nano strip connector, Omnetics, Minneapolis, USA) was affixed using 
dental cement to the cranium and the wound sutured around the implant. Mice’s recovery and well-being was closely 
monitored until they were fully recovered (approximately ten days).
Visual discrimination (VD) Task.  Apparatus. Mice were tested in customized operant chambers (modi-
fied from Med Associates Inc. Fairfax, Vermont): two sides of the box were constructed of clear Perspex. One of 
the other two sides was equipped with a pellet receptacle containing a light and an infra-red nose-poke detector, a 
tone generator, and a house light. The remaining side of the box was equipped with a touch-sensitive, flat-screen, 
LCD computer monitor. Nose-poking on the screen was detected with an infrared touch detection system. The 
monitor was then covered with a “mask”, a piece of black Perspex with two aperture plate dividing the touchscreen 
into two response fields (75 mm × 75 mm) in which visual stimuli were presented. Boxes were placed in sound 
attenuated chambers fitted with a small ventilation fan that also provided a mild masking background noise. The 
floor of the chamber consisted of aluminum bars spaced approximately 1 cm apart. Each operant box was con-
trolled by K-limbic software, version 1.20.2 (Conclusive Solutions, Sawbridgeworth, UK).
Condition Brain Area Freq Z Prob > [Z] p value rank FDR threshold
Task_Start
Cg
LG −0.6365 0.5244 14 0.0292
HG 0.28932 0.7723 20 0.0417
HFO −0.6365 0.5244 15 0.0313
dCA1
LG −2.22354 0.0262 1 0.0021
HG −0.27116 0.7863 21 0.0438
HFO −1.57275 0.1158 2 0.0042
DMS
LG 0.17359 0.8622 23 0.0479
HG 0.98368 0.3253 9 0.0188
HFO −1.33087 0.1832 5 0.0104
RSC
LG −0.74096 0.4587 12 0.0250
HG 0.10585 0.9157 24 0.0500
HFO −0.74096 0.4587 13 0.0271
Task_End
Cg
LG 0.86796 0.3854 11 0.0229
HG 1.56232 0.1182 3 0.0063
HFO −0.6365 0.5244 16 0.0333
dCA1
LG −1.24735 0.2123 6 0.0125
HG −0.59656 0.5508 17 0.0354
HFO −1.24735 0.2123 7 0.0146
DMS
LG 1.33087 0.1832 4 0.0083
HG 0.40505 0.6854 19 0.0396
HFO −1.09941 0.2716 8 0.0167
RSC
LG 0.2117 0.8323 22 0.0458
HG 0.4234 0.672 18 0.0375
HFO −0.95266 0.3408 10 0.0208
Table 3. Between-subject analysis of phase-amplitude coupling (PAC) during the visual discrimination (VD) task. 
Conditions: Task_Start = start of the VD task, Task_End = end of the VD task. Brain areas: Cingulate Cortex (Cg), 
dorsal CA1 region of the hippocampus (dCA1), dorsal medial striatum (DMS), and retrosplenial cortex (RSC). 
Frequencies: low gamma (LG), high gamma (HG), and high frequency oscillations (HFO). Z: Wilcoxon rank-sum 
test. Significance level at q = 0.05, false discovery rate (FSD) corrected for multiple comparisons.
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touchscreen pre-training stages. The shaping of animals to use touch screens to respond to stimulus 
images consisted of five pre-training stages25. All mice began pretraining at 3.5 months of age and progressed 
from each stage on an individual basis based on their performance (i.e. reaching a pre-set performance criterion).
Habituation. The first stage aimed to familiarize the mice with the operant chambers and extractor fan noise. 
Mice were placed in the boxes, lights off, for 30 minutes and given 10 reward pellets (TestDiet, USA). Mice were 
required to consume all reward pellets during the session to progress to the next stage.
Tone association. In this stage mice established an association between a tone and reward delivery. A reward 
was delivered with a tone to begin the session. The food magazine light remained on from reward delivery until 
collection. The next reward and tone were delivered after a 30 second inter-trial interval (ITI) when the mouse 
entered the food magazine. Mice were required to complete 60 trials within 60 minutes for two consecutive days 
to advance to the next stage.
Touch association. Here, mice were encouraged to touch the screen to receive the reward. During trials, a white 
square was presented in one of the two response windows for 30 seconds. The location of the stimulus presenta-
tion was pseudo-random between trials. If mice touched the square during this time a food reward was delivered 
with a tone and a 10 second ITI initiated. Otherwise, the stimulus was removed, and the house light switched on 
for 10 seconds followed by a 10 second ITI. There was no penalty for touching the other response window. Mice 
were required to complete a minimum of 35 trials in 45 minutes to advance to the next stage.
Must touch. During this stage the association between screen touches and rewards was reinforced. The pro-
cedure and success criterion were the same as in the Touch Association stage, however new trials did not begin 
automatically after 30 seconds – animals were required to touch the illuminated square before the next trial could 
begin. Animals were required to complete a minimum of 35 trials in 45 minutes to advance to the next stage.
Punish incorrect. The final stage of pretraining introduced a penalty for indiscriminate screen touches. The trials 
proceeded as in the Must Touch stage but touches to the non-illuminated response window triggered a 5 second 
timeout with the house light on, followed by a 10 second ITI. These trials were recorded as incorrect and followed 
by a CT. During all CTs the stimulus presentation was in the same location as the preceding trial, and the trail 
Condition
Brain 







Theta 0.6365 0.5244 14 0.0291667
Gamma −0.05786 0.9539 24 0.05
HFO −0.40505 0.6854 19 0.0395833
dCA1
Theta 0.88388 0.3768 9 0.01875
Gamma 0.29463 0.7683 20 0.0416667
HFO 0.76603 0.4437 11 0.0229167
DMS
Theta 0.63888 0.5229 13 0.0270833
Gamma −0.5111 0.6093 17 0.0354167
HFO −0.7665 0.4433 10 0.0208333
RSC
Theta 0.28932 0.7723 21 0.04375
Gamma −0.40505 0.6854 18 0.0375
HFO −0.52077 0.6025 16 0.0333333
8_Months
Cg
Theta −0.96825 0.3329 7 0.0145833
Gamma 0.71005 0.4777 12 0.025
HFO 1.74284 0.0814 2 0.0041667
dCA1
Theta −0.13333 0.8415 23 0.0479167
Gamma 0.26667 0.7897 22 0.0458333
HFO 1.2 0.2301 5 0.0104167
DMS
Theta −1.5 0.1336 3 0.00625
Gamma 2.07143 0.0383 1 0.0020833
HFO 0.92857 0.3531 8 0.0166667
RSC
Theta 1.09735 0.2725 6 0.0125
Gamma −0.58095 0.5613 15 0.03125
HFO −1.22644 0.22 4 0.0083333
Table 4. Between-subject analysis of relative power spectral density (PSD) during the no-task condition. 
Conditions: 5 and 8 months of age. Brain areas: Cingulate Cortex (Cg), dorsal CA1 region of the hippocampus 
(dCA1), dorsal medial striatum (DMS), and retrosplenial cortex (RSC). Frequencies: theta, gamma, and high 
frequency oscillations (HFO). Z: Wilcoxon rank-sum test. Significance level at q = 0.05, false discovery rate 
(FSD) corrected for multiple comparisons.
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repeated until the animal responded to the correct window. Outcomes during correction trials were not included 
in trial count or any analyses. Mice progressed from this stage once they could achieve ≥75% correct responses 
over a minimum of 30 trials for two consecutive days. The number of trials was capped at 80. During this stage 
of the pretraining regime mice were fitted with headstages used for the LFPs recordings on alternating test days 
to acclimatize them to wearing the headstage. After this step mice were ready to advance to the VD task testing.
Visual discrimination (VD) task testing.  VD testing began when mice were at an age of 4.5 months old. In 
VD sessions, a pair of images previously validated25 (Fig. 2a) were presented on screen. Based on a subject’s counter-
balanced group assignment, each image was designated as either the conditioned stimulus (S+) or the unconditioned 
stimulus (S−) and the reward-contingency of the image was kept constant for each mouse across the experiment. 
Responses to S+ were rewarded with a food pellet, while responses to S− were recorded as incorrect and resulted in 
a 5 s timeout with the house light on. As in the Punish Incorrect pretraining stage, incorrect trials were followed by 
CTs in which stimulus locations were kept the same. Stimulus presentations occurred in a pseudo-random location 
in each trial, never appearing in the same window in more than three consecutive trials (excluding CTs) and total 
presentations counterbalanced between the two locations. Mice completed one 45-minute session (max 80 trials) 
of VD testing daily until they achieved an acquisition criterion set as two consecutive sessions at ≥80% correct 
responses over a minimum of 30 trials. For an illustration of the VD task see Fig. 2b.
Local field potentials (LFPs) analysis.  Recordings. LFPs were recorded with a sample frequency of 
1000 Hz, high-pass filtered above 1 Hz, and referenced to the ground electrode placed midline above the cerebel-
lum using small-size W4-HS wireless headstages weighing approximately 2.2 grams including battery, connected 
to a W2100 system (Multichannel systems, Germany. All analyses were done with built-in and custom-written 
routines in MATLAB (MathWorks, 2014a). Detection of artefacts and wrongly placed electrodes was carried out 
in three steps. Firstly, data were visually inspected and electrodes with noise were excluded for further analysis. 
Secondly, epochs were excluded during the Matlab analysis using an amplitude method (i.e. artefact rejection) 
with a standard deviation cut-off of 10. Finally, at the end of the experiment, mice were deeply anesthetized and 
electrolytical lesions were produced at the selected recording sites using a current generator apparatus (500 µA for 
30 seconds, MC Stimulus II, Multichannel systems, Germany), then mice were euthanized, and their brain tissue 
was frozen in dry-ice cooled methylbutane. Coronal sections of frozen brains were obtained using a cryostat and 
counterstained for histological verification of subcortical electrode placements.
LFPs were recorded and analysed in two conditions:
Condition
Brain 







LG −0.68264 0.4948 12 0.02609
HG 1.31276 0.1893 6 0.01304
HFO −0.26255 0.7929 22 0.04783
dCA1
LG −1.37607 0.1688 3 0.00652
HG −0.52926 0.5966 14 0.03043
HFO −0.31755 0.7508 19 0.04130
DMS
LG 1.44659 0.148 1 0.00217
HG 0.52077 0.6025 15 0.03261
HFO 0.28932 0.7723 21 0.04565
RSC
LG 0.36757 0.7132 18 0.03913
HG 1.20774 0.2271 7 0.01522
HFO −0.15753 0.8748 24 0.05217
8_Months
Cg
LG −0.40505 0.6854 16 0.03478
HG −0.40505 0.6854 17 0.03696
HFO 1.33087 0.1832 5 0.01087
dCA1
LG −1.35529 0.1753 4 0.00870
HG −0.88388 0.3768 10 0.02174
HFO −0.53033 0.5959 13 0.02826
DMS
LG 0.7665 0.4433 11 0.02391
HG 1.14998 0.2502 8 0.01739
HFO 0.89443 0.3711 9 0.01957
RSC
LG −0.28932 0.7723 20 0.04348
HG −0.17359 0.8622 23 0.05000
HFO 1.44659 0.148 2 0.00435
Table 5. Between-subject analysis of phase-amplitude coupling (PAC) during the no-task condition. 
Conditions: 5 and 8 months of age. Brain areas: Cingulate Cortex (Cg), dorsal CA1 region of the hippocampus 
(dCA1), dorsal medial striatum (DMS), and retrosplenial cortex (RSC). Frequencies: low gamma (LG), high 
gamma (HG), and high frequency oscillations (HFO). Z: Wilcoxon rank-sum test. Significance level at q = 0.05, 
false discovery rate (FSD) corrected for multiple comparisons.
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•	 VD task: Neuronal and behavioral data were synchronized with a precision of 10 milliseconds using a tran-
sistor-transistor logic output signal generated by the food magazine light of the operant box. Recordings of 
the first (Task_Start) and last (Task_End) session of the VD task were included in the study. Response and 
collection latency data were used to select an epoch for analysis within each trial of 1.4 second prior to a cor-
rect touchscreen response (Fig. 2b). This value was used to maximize the length of the window containing 
brain activity related to choice-making immediately prior to screen touch while avoiding inclusion of activity 
related to trial initiation.
•	 Home-cage monitoring: Mice at 5 and 8 months of age were placed for 1 hour in their home-cage environ-
ment with a camera (UI-3140CP-C-HQ Rev.2, IDS Imaging, Germany) above the cage to record their activity 
for synchronization with recorded LFPs. Home-cages were placed in sound attenuated chambers fitted with 
a small ventilation fan that also provided a mild masking background noise. Behavioral activity was scored 
using Smart software v3.0 (Panlab, Barcelona) and categorized into different activity levels based on speed 
and only segments where the speed of the mice was between 2 and 30 cm/sec were considered for the analysis. 
Using a sliding window approach, we selected LFPs data at 1.4 seconds epochs for further analysis. The speed 
and epoch’s length parameters were selected to match behavioral task conditions.
Relative power spectral density (PSD) analysis.  Welch’s power spectral density was estimated and 
analyzed for frequencies ranging from 4 to 200 Hz for each epoch for the different conditions. PSD values were 
averaged in 1 Hz frequency bins across trials within a session for each subject and brain region and power was 
expressed as relative power to the total power over 4 to 200 Hz. For statistical analysis relative PSD data were 
averaged across theta (4–12 Hz), gamma (30–100 Hz) and HFO (101–200 Hz).
Figure 8. Amyloid β pathology in AppNL-G-F mice. (a) Biochemical quantification of Aβ1–42 in AppNL-G-F 
forebrains (GuHCl fraction) measured by sandwich ELISA. Standard curves for calibration were generated 
using synthetic human Aβ1–42 peptide. Data represent the mean of 2 to 4 independent measurements of 
pooled samples with each pool consisting of equal volumes of extracts from 4 to 6 mice (n = 5, 6, 5, 4, 4, 6, 6 
per indicated time point respectively). Star symbols indicate significance compared to 2 mo (months of age). 
(b,c) Example images and immunohistochemical analysis of the plaque occupancy area in cortex (inset) and 
hippocampus using a C-terminal antibody (JRF/cAβ42/26, b) or N-terminal antibody (JRF/AβN/25. (c) Scale 
bars in the photographs are 2.5 mm and 50 µm (inset). In the summarizing plots, mean and SD are presented 
in a bar chart in which each superimposed dot representing a single animal. Star symbols indicate significance 
compared to 2 mo.
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Phase amplitude coupling (PAC).  The signal was convoluted with complex Morlet wavelets to extract 
estimates of time-varying frequency band-specific amplitude and phase from the LFPs data. Theta-gamma PAC 
was calculated using an algorithm described previously27. The MI was used to quantify the modulation of the high 
frequency amplitude signal (30–200 Hz, estimated in 5 Hz steps) by a low frequency phase signal (4–12 Hz, esti-
mated in 0.5 Hz steps). While a MI value close to zero indicates no relationship between low frequency phase and 
high frequency amplitude, a higher value results from stronger phase-to-amplitude modulation. Due to the short 
duration of the analysis window (1.4 seconds), within each epoch a lengthiest segment with integer number of 
cycles for the considered low frequency phase was extracted, and values of analytical signals for all the segments 
within a session were aggregated (over time) in a complex phase space prior to MI estimations for each mice and 
electrode. For statistical analysis MI were averaged across the amplitude frequency low gamma (30–60 Hz), high 
gamma (61–100 Hz) and HFO (101–200 Hz).
Statistics. Statistical analyses were conducted using JMP®, version 12 (SAS Institute Inc, NC, US). For behav-
ioral testing, the distributions of dependent variables were assessed for meeting the assumption of normality 
required in parametric statistical tests. Group comparisons were made using a two-tailed two-sample t-test, or the 
normal approximation to the Wilcoxon rank-sum test (reported as Z) was used if the data did not meet the nor-
mality assumption. A mixed-effect model for repeated measures with genotype, and session as fixed effects and 
subject as a random effect was used to investigate percentage of correct responses during the VD task. Residuals 
of models were inspected for normality and an alpha level of p = 0.05 was used to determine significance in all 
statistical tests. For electrophysiological statistical testing, most data were non-normally distributed and nonpar-
ametric test were applied. For within-subject analysis the delta value between the two conditions was calculated 
and compared to zero. Significance was tested using the Wilcoxon signed-rank test (reported as Z). Correction 
for multiple comparison was performed using the Benjamini-Hochberg procedure with a false discovery rate 
threshold of q = 0.0560,61. For clear representation of the data all descriptive statistics, such as mean, median, SD, 
and ranges, together with p values and thresholds are presented in tables (either in the text or as supplementary 
material) and box plots with individual points for each subject are used, rather than commonly reported bars 
graphs62. Box plots represent the interquartile range; the solid line inside the box indicates the median, the box 
represents 50% of data points between the first and third quartile, and the upper and lower whiskers represent 
scores outside the middle 50%.
In Vitro experimental methods. Animals. A separate, satellite group of AppNL-G-F male mice were 
group-housed in individually ventilated cages under a reversed 12–12 light cycle (lights off 07:00–19:00; light 
intensity ~100 lux) and controlled environmental conditions throughout the study (22 ± 2 °C ambient temper-
ature and relative humidity at 60%). Home cages were equipped with corn cob bedding, a tinted polycarbonate 
shelter and tissue for nesting material. Food and water were provided ad libitum.
tissue collection and processing. Mice were euthanized by decapitation after which brains were excised. 
Olfactory lobes and hindbrain were removed from tissue processed for biochemistry. Brain hemispheres were 
weighed, immediately frozen on dry ice and stored at −80 °C prior to biochemical (right hemisphere) analysis. 
For the preparation of brain homogenates, tissue was thawed on ice in pre-cooled GuHCl extraction buffer (5 M 
Guanidin-hydrochloride, 50 mM Tris-HCl, pH 8.0, 1 mL/100 mg tissue). Homogenization was done utilizing 
4.5 mL TallPrep tubes (MP Biomedicals) containing Lysing matrix D (1.4 mm ceramic beads) and FastPrep-24 
5 G homogenizer (MP Biomedicals). Subsequently, homogenates were shaken for 3 hours at room temperature 
and stored at −80 °C until further use. The left hemisphere was post-fixed overnight in a formalin-based fixative, 
embedded in paraffin and sliced (5 µm) with a microtome.
Brain Aβ1–42 elisa.  Aβ1–42 in AppNL-G-F brain extracts were quantified in a one-step direct sandwich ELISA 
with capture antibody JRF/cAβ42/26 that specifically recognizes Aβ ending at amino acid 42, and detection with 
SULFOTAG™-labelled 3D6 antibody that recognizes Aβ starting with amino acid 1. Equal volumes of brain 
homogenates of different mice belonging to the same age group (4 to 6 mice per time point) were pooled and 
then further diluted 1:10 in casein buffer (0.1% casein in PBS). Next, samples were spun for 20 minutes at 20.000 g 
(4 °C) and supernatants was collected to be further diluted in 0.5 M GuHCl buffer to optimal dilutions for use in 
the assay. Human Aβ1–42 standard peptide (Anaspec, San Jose, CA, USA) was dissolved in DMSO at 0.1 mg/mL 
and stored at −80 °C. For use in ELISA, standards were diluted in 0.5 M GuHCl buffer from 20.000 pg/mL down 
to 0 pg/mL.
Capture antibody was diluted in PBS (1.5 µg/mL), coated onto Multi-array 96-well SECTOR plates (Meso 
Scale Discovery, L15XA, 30 µL/well) and incubated overnight at 4 °C. After 5 washes with PBS containing 
0.5% Tween20 (wash buffer), the plates were blocked in 0.1% casein buffer (2 hours at room temperature 
while shaking) and washed again with wash buffer (5x). Prior to their addition to the plates, samples and 
standards were mixed in an equal volume of SULFOTAG™-labelled detection antibody (diluted in 0.1% 
casein buffer) and were subsequently incubated on the plates overnight at 4 °C. The next day, plates were 
washed 5 times with wash buffer, 2 × MSD Read Buffer T was added to the wells and plates were immediately 
read with the MESO SECTOR S 600 plate reader. Using Meso Scale software, raw signals were normalized 
against the standard curve.
immunohistochemistry. Following deparaffinization and rehydration of the sections, antigen retrieval was 
performed (10 minutes incubation in 70% formic acid) and endogenous peroxidase activity was blocked with 
3% hydrogen peroxide. Samples were incubated overnight with biotinylated primary antibodies (JRF/cAβ42/26 
2 µg/mL; JRF/AβN/25 1 µg/mL63), diluted in antibody diluent with background reducing components (DAKO, 
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Glostrup, Denmark). After extensive washing, streptavidin-HRP solution (Vector Labs, Burlingame, CA, USA) 
was applied for 30 minutes, followed by chromogenic labelling with 3,3-diaminobenzidine (DAB, DAKO). Slides 
were counterstained with hematoxylin, dehydrated and permanently mounted (Vectamount, Vector Labs). 
Imaging was performed with a NanoZoomer slide scanner (Hamamatsu Photonics, Shizuoka, Japan) and ana-
lysed with Matlab/Phaedra. Regions-of-interest (ROIs) were manually delineated in accordance with the Franklin 
and Paxinos atlas59 and for each ROI the percentage of DAB-labelled area per total area was calculated.
Statistical analysis. Statistical analyses were conducted using GraphPad Prism, version 8 (GraphPad 
Software, Inc.). Using the Shapiro-Wilk test, the distributions of dependent variables were assessed for meeting 
the assumption of normality required in parametric statistical tests. Multiple group comparisons were made using 
the Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test. Data were considered 
significant when p < 0.05 (one symbol p < 0.05, two symbols, p < 0.01, three symbols p < 0.001, four symbols 
p < 0.0001).
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